CIK 0001840706 · Accelerated filer<br>Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41 21 694 10 60
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- Open-market buys, last 90 days
- $278,388
- in 2 filings
- Open-market sales, last 90 days
- $1,679,030
- in 28 filings, $1.6M under 10b5-1 plans
Net −$1,400,642. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-07 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −20,000 | $7.23 | $145K | 3,452,822 |
| 2026-08-07 | Xu Zhenyu Chief Scientific Officer | Option exercise 10b5-1 | +7,000 | $3.28 | $23K | 607,887 |
| 2026-08-07 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −7,000 | $7.02 | $49K | 600,887 |
| 2026-08-07 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −10,000 | $7.48 | $75K | 590,887 |
| 2026-08-07 | Xu Zhenyu Chief Scientific Officer | Option exercise · Share Option (Right to Buy) 10b5-1 | −7,000 | $3.28 | $23K | 0 |
| 2026-08-05 | Xu Zhenyu Chief Scientific Officer | Option exercise 10b5-1 | +3,000 | $3.28 | $10K | 603,887 |
| 2026-08-05 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −3,000 | $7.00 | $21K | 600,887 |
| 2026-08-05 | Xu Zhenyu Chief Scientific Officer | Option exercise · Share Option (Right to Buy) 10b5-1 | −3,000 | $3.28 | $10K | 7,000 |
| 2026-08-04 | Verma Abhimanyu Chief Technology Officer | Sale 10b5-1 | −5,000 | $6.95 | $35K | 187,171 |
| 2026-08-04 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −20,000 | $6.92 | $138K | 3,472,822 |
| 2026-08-04 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −10,000 | $6.92 | $69K | 600,887 |
| 2026-07-27 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −5,000 | $5.66 | $28K | 223,387 |
| 2026-07-21 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −20,000 | $6.63 | $133K | 3,492,822 |
| 2026-07-20 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −19,800 | $6.32 | $125K | 3,512,822 |
| 2026-07-20 | Camblong Jurgi Executive Chairman | Option exercise 10b5-1 | +4,581 | $3.16 | $14K | 3,517,403 |
| 2026-07-20 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −4,581 | $6.17 | $28K | 3,512,822 |
| 2026-07-20 | Camblong Jurgi Executive Chairman | Option exercise · Share Option (Right to Buy) 10b5-1 | −4,581 | 0 | ||
| 2026-07-13 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −5,000 | $5.70 | $29K | 228,387 |
| 2026-07-13 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −4,000 | $5.70 | $23K | 610,887 |
| 2026-07-10 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −8,500 | $5.62 | $48K | 3,532,622 |
Page 3 of 8 · 157 trades